Gioana Litscher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gioana Litscher has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Annette Oxenius
Institute of Microbiology ETH Zürich Zürich Switzerland
1 shared publication - Burkhard Becher
Institute of Experimental Immunology, University of Zurich, Switzerland
1 shared publication - Caroline Mussak
Institute of Experimental Immunology, University of Zürich 1 , Zürich
1 shared publication - Christin Friedrich
Wuerzburg Institute of Systems Immunology (WueSI), Max Planck Research Group at the Julius-Maximilians-Universitaet Wuerzburg, Wuerzburg, Germany
1 shared publication - Colin Sparano
Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland
1 shared publication - Darío Solís-Sayago
Institute of Experimental Immunology, University of Zürich 1 , Zürich
1 shared publication
Latest Publications
- Open Access
- 18 December 2024
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (3)
Autocrine TGF-β1 drives tissue-specific differentiation and function of resident NK cells
Group 1 innate lymphoid cells (ILCs) encompass NK cells and ILC1s, which have non-redundant roles in host protection against pathogens and cancer. Despite their circulating nature, NK cells can establish residency in selected tissues during ontogeny, forming a distinct functional subset. The mechanisms that initiate, maintain, and regulate the conversion of NK cells into tissue-resident NK (trNK) cells are currently not well understood. Here, we identify autocrine transforming growth factor-β (TGF-β) as a cell-autonomous driver for NK cell tissue residency across multiple glandular tissues during development. Cell-intrinsic production of TGF-β was continuously required for the maintenance of trNK cells and synergized with Hobit to enhance cytotoxic function. Whereas autocrine TGF-β was redundant in tumors, our study revealed that NK cell–derived TGF-β allowed the expansion of cytotoxic trNK cells during local infection with murine cytomegalovirus (MCMV) and contributed to viral control in the salivary gland. Collectively, our findings reveal tissue-specific regulation of trNK cell differentiation and function by autocrine TGF-β1, which is relevant for antiviral immunity.
- 18 December 2024
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (3)
Open AccessAutocrine TGF-β1 drives tissue-specific differentiation and function of resident NK cells
Group 1 innate lymphoid cells (ILCs) encompass NK cells and ILC1s, which have non-redundant roles in host protection against pathogens and cancer. Despite their circulating nature, NK cells can establish residency in selected tissues during ontogeny, forming a distinct functional subset. The mechanisms that initiate, maintain, and regulate the conversion of NK cells into tissue-resident NK (trNK) cells are currently not well understood. Here, we identify autocrine transforming growth factor-β (TGF-β) as a cell-autonomous driver for NK cell tissue residency across multiple glandular tissues during development. Cell-intrinsic production of TGF-β was continuously required for the maintenance of trNK cells and synergized with Hobit to enhance cytotoxic function. Whereas autocrine TGF-β was redundant in tumors, our study revealed that NK cell–derived TGF-β allowed the expansion of cytotoxic trNK cells during local infection with murine cytomegalovirus (MCMV) and contributed to viral control in the salivary gland. Collectively, our findings reveal tissue-specific regulation of trNK cell differentiation and function by autocrine TGF-β1, which is relevant for antiviral immunity.